PROFOUND MEDICAL CORP. Operating Lease, Lease Income
PROFOUND MEDICAL CORP. (PROF) reported Operating Lease, Lease Income of $230.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseLeaseIncome · last filed 2025-11-13
- PROFOUND MEDICAL CORP. operating lease, lease income for the quarter ending 2025-09-30 was $230.00K, a 20.69% decline year-over-year.
- PROFOUND MEDICAL CORP. operating lease, lease income for the quarter ending 2025-06-30 was $230.00K, a 17.86% decline year-over-year.
- PROFOUND MEDICAL CORP. operating lease, lease income for the quarter ending 2025-03-31 was $280.00K, a 27.27% increase year-over-year.
- PROFOUND MEDICAL CORP. operating lease, lease income for the quarter ending 2024-12-31 was $150.00K.
- PROFOUND MEDICAL CORP. operating lease, lease income for fiscal 2024 was $940.00K, a 27.69% decline from fiscal 2023.
- PROFOUND MEDICAL CORP. operating lease, lease income for fiscal 2023 was $1.30M.
| Period end | Operating Lease, Lease Income 3 month | Operating Lease, Lease Income 6 month | Operating Lease, Lease Income 9 month | Operating Lease, Lease Income 12 month |
|---|---|---|---|---|
| 2025-09-30 | $230.00K 10-Q · filed 2025-11-13 | $460.00K derived: sum of 2 quarters · filed 2025-11-13 | $740.00K 10-Q · filed 2025-11-13 | $890.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | $230.00K 10-Q · filed 2025-08-14 | $510.00K 10-Q · filed 2025-08-14 | $660.00K derived: sum of 3 quarters · filed 2025-08-14 | $950.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | $280.00K 10-Q · filed 2025-05-08 | $430.00K derived: sum of 2 quarters · filed 2025-05-08 | $720.00K derived: sum of 3 quarters · filed 2025-11-13 | $1.00M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $440.00K derived: sum of 2 quarters · filed 2025-11-13 | $720.00K derived: sum of 3 quarters · filed 2025-11-13 | $940.00K 10-K · filed 2025-03-07 |
| 2024-09-30 | $290.00K 10-Q · filed 2025-11-13 | $570.00K derived: sum of 2 quarters · filed 2025-11-13 | $790.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $280.00K 10-Q · filed 2025-08-14 | $500.00K 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $220.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $1.30M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |